RxDoctor Payments Data

Jennifer Stirgwolt, DO

Family Medicine · Aylett, VANPI 1417117391

Payments from drug & device makers

$439in general payments, 2019–2025

Across 31 payments — averaging $14.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$94
  • Sunovion Pharmaceuticals Inc.$66
  • Takeda Pharmaceuticals U.S.A., Inc.$43
  • AbbVie$37
  • Lilly USA, LLC$35
  • Alkermes, Inc.$34
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$43298%
  • Education$72%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$439 in reported general payments places this provider in the 55th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$436
Medicare patients
28
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol70$70,638
OzempicSemaglutide61$57,536
EliquisApixaban48$48,208
TrulicityDulaglutide35$36,116
LinzessLinaclotide38$30,124
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$26,824
JanuviaSitagliptin Phosphate19$26,114
JardianceEmpagliflozin22$21,441
XareltoRivaroxaban15$18,506
EntrestoSacubitril/Valsartan19$16,123
Breo ElliptaFluticasone/Vilanterol29$14,933
MounjaroTirzepatide12$12,622
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$11,566
Fluticasone-SalmeterolFluticasone Propion/Salmeterol66$10,816
Spiriva HandihalerTiotropium Bromide20$10,361

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$94$57,53661 claims
PfizerEliquis, Premarin$23$53,37567 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$23$53,32384 claims
Lilly USA, LLCTrulicity, Mounjaro$35$48,73847 claims
AbbVieLinzess$37$30,12438 claims
Boehringer IngelheimJardiance$17$21,44122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Aylett

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →